# Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy

> **NCT01292070** · EARLY_PHASE1 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 4 (actual)

## Conditions studied

- Cat Allergy

## Interventions

- **BIOLOGICAL:** Intradermal Human Fcγ1-Fel d1 fusion protein
- **BIOLOGICAL:** Positive Control - standardized cat hair allergenic extract (CAT)
- **BIOLOGICAL:** Positive Control - Histamine Prick
- **BIOLOGICAL:** Negative Control - Intradermal Diluent

## Key facts

- **NCT ID:** NCT01292070
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2014-02-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01292070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01292070, "Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01292070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*